LUO, Peter Peizhi,DU, Fangyong,PAN, Zhongzong,LIU, Guizhong
申请号：
AU2019214188
公开号：
AU2019214188A1
申请日:
2019.02.02
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Provided herein are cross-reactive antibodies (or antigen binding fragments thereof) that bind to human CTLA4, activatable antibodies that bind to human CTLA4, nucleic acid molecules encoding the same, pharmaceutical compositions thereof, and methods of their therapeutic use (e.g., for treatment of cancer).
